Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0,15%
1 095,47
+1,66
+0,15%
—1 093,811 096,521 100,221 093,20——
SIXC
Communications
SIXC
Communications
SIXC
+0,24%
610,21
+1,44
+0,24%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,28%
1 238,77
-16,04
-1,28%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,75%
1 747,90
-13,21
-0,75%
—1 761,111 764,271 766,881 745,39——
SIXM
Financials
SIXM
Financials
SIXM
-0,17%
641,51
-1,07
-0,17%
—642,58644,87648,48641,42——
SIXR
Staples
SIXR
Staples
SIXR
-0,46%
847,19
-3,94
-0,46%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,39%
217,12
-0,86
-0,39%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,44%
3 258,17
+46,34
+1,44%
—3 211,833 227,213 267,763 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,72%
942,16
-6,82
-0,72%
—948,98948,58957,83942,19——
SIXV
Health care
SIXV
Health care
SIXV
-0,27%
1 470,49
-4,03
-0,27%
—1 474,521 479,031 481,041 469,17——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,44%
2 402,58
+10,46
+0,44%
—2 392,122 396,952 421,222 382,32——
4502:TYO
Takeda Pharmaceutical Co Ltd
5 239,00 JP¥
-0,59%
(-31,00) 1D
1 մյս, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4502...
Open
5 260 JP¥
High
5 260 JP¥
Low
5 191 JP¥
Mkt. cap
8,34 տրլն
Avg. vol.
4,37 մլն
Volume
2,63 մլն
Dividend
3,78%
Quarterly dividend
49 JP¥
Ex dividend date
29 սեպ, 2025 թ.
P/E ratio
72,50
52-wk high
6 033 JP¥
52-wk low
4 000 JP¥
EPS
72 JP¥
Shares outstanding
784,48 մլն
No. of employees
47 հզր
News stories
From sources across the web
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. Wikipedia
About Takeda Pharmaceutical Co Ltd
CEOChristophe Weber | Christophe Weber
Employees47,5 հզր
Founded12 հնս, 1781 թ.
Headquarters-
Sector-
Websitetakeda.com
Last report
29 հնվ, 2026 թ.
Fiscal Period
Q3 2026
Normalized EPS / Estimate
-/ -JPY
Revenue / Estimate
1,19 տրլն/ (1,20 տրլն est.)JPY
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
2025 թ. մրտ
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
Revenue
1,05 տրլն
1,11 տրլն
1,11 տրլն
1,19 տրլն
Cost of goods sold
373,28 մլրդ
384,68 մլրդ
380,06 մլրդ
401,15 մլրդ
Cost of revenue
373,28 մլրդ
384,68 մլրդ
380,06 մլրդ
401,15 մլրդ
Research and development expenses
216,01 մլրդ
143,89 մլրդ
161,48 մլրդ
175,23 մլրդ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
295,83 մլրդ
255,88 մլրդ
253,55 մլրդ
282,78 մլրդ
Operating expense
557,10 մլրդ
535,14 մլրդ
562,57 մլրդ
661,30 մլրդ
Total operating expenses
930,38 մլրդ
919,82 մլրդ
942,63 մլրդ
1,06 տրլն
Operating income
123,02 մլրդ
186,86 մլրդ
170,17 մլրդ
129,25 մլրդ
Other non operating income
-24,86 մլրդ
-77,96 մլրդ
77,96 մլրդ
-294,52 մլրդ
EBT including unusual items
-107,30 մլրդ
150,63 մլրդ
28,17 մլրդ
133,86 մլրդ
EBT excluding unusual items
100,18 մլրդ
152,93 մլրդ
128,86 մլրդ
114,17 մլրդ
Income tax expense
-4,20 մլրդ
26,35 մլրդ
39,90 մլրդ
30,13 մլրդ
Effective tax rate
3,92%
17,49%
141,64%
22,51%
Other operating expenses
-91,26 մլրդ
6,03 մլրդ
16,12 մլրդ
67,13 մլրդ
Net income
-103,16 մլրդ
124,24 մլրդ
-11,80 մլրդ
103,64 մլրդ
Net profit margin
-9,79%
11,23%
-1,06%
8,70%
Earnings per share
-
-
-
-
Interest and investment income
9,85 մլրդ
73,76 մլրդ
43,92 մլրդ
278,65 մլրդ
Interest expense
-7,82 մլրդ
-29,20 մլրդ
-161,10 մլրդ
-
Net interest expenses
2,03 մլրդ
44,56 մլրդ
-117,18 մլրդ
278,65 մլրդ
Depreciation and amortization charges
-
-
-
-
EBITDA
221,72 մլրդ
368,50 մլրդ
355,15 մլրդ
182,70 մլրդ
Gain or loss from assets sale
-2,39 մլրդ
-17,32 մլրդ
303,00 մլն
358,00 մլն
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer